PROM

BioElectronics Corporation Announces the Publication of a Canine Arthritis Study

Retrieved on: 
Monday, March 25, 2024
Prevalence, Exercise, Gastrointestinal bleeding, Risk, GI, Sale, Nonsteroidal anti-inflammatory drug, Running, Veterinary medicine, Motion, OA, Chronic pain, Quality of life, Osteoarthritis, Arthritis, Dog, PROM, Aspirin, Cartilage, Bioelectronics, FDA, Animal, BIEL, Ibuprofen, Audit

Forty-nine animals completed the study. No negative side effects were reported. Average subjective discomfort scores for the treatment group (N=26) were reduced from 4.26 to 2.31 (45%) compared to no improvement in the placebo group (N=23) over the study period. Average PROM scores increased by 5.51 (4.59--6.23) degrees relative to the placebo group. Ninety-six percent of the treatment group showed either increased PROM or improved behavioral changes or both compared to 4% for the placebo group. Most changes occurred within the first 8 days of treatment.

Key Points: 
  • The study was published online by Veterinary Medicine & Science, and can be viewed here: https://doi.org/10.1002/vms3.1408
    A randomized, blinded, placebo-controlled 14-day study of 60 dogs having prior veterinary-diagnosis OA in at least one limb joint.
  • BioElectronics’ Model 088 device was secured near the cervical region of the dog’s spine.
  • Osteoarthritis is the most common type of arthritis in dogs and is the most common source of chronic pain in older dogs.
  • Armed with these published results, BioElectronics Corporation will pursue appropriately qualified distribution partners to market and sell its unique pulsed shortwave device into the veterinary medicine market.

Reverse Hip Replacement System Unveiled at Global Orthopedic Surgery Meeting

Retrieved on: 
Thursday, February 15, 2024
JIS, SAN, Collection, Division, Total, PROM, Roentgen stereophotogrammetry, MD, Physician, FDA, Effectiveness, Orthopedic surgery, Quality of life, Shore Medical Center, Dislocation, HRS, IDE, Eye, Entrepreneurship, RSA, Agency, Risk, Narration, Safety, Arthralgia, THA, Patient, HIT, Hip, Investigational device exemption, AAOS, Reverse, Roentgen, Motion, American Academy, Medical device

SAN FRANCISCO, Feb. 15, 2024 /PRNewswire/ -- Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and quality of care for patients, today announced that its flagship product, the Reverse Hip Replacement System (Reverse HRS) was showcased at the 2024 American Academy of Orthopaedic Surgeons (AAOS) annual meeting, taking place in San Francisco, CA from February 12 -16, 2024.

Key Points: 
  • "We are extremely excited that the Reverse HRS was featured at AAOS in the OrthoDome with a video of an actual hip replacement surgery narrated by Dr. Adolph Lombardi," said George Diamantoni, Hip Innovation Technology's Co-Founder and Chief Executive Officer.
  • The presentation featured high resolution video of Dr. Lombardi conducting a hip replacement with the new Reverse HRS.
  • The Bone & Joint Open journal, recently published the article, "Radiostereometric analysis and clinical outcomes of a novel reverse total hip system at two years."
  • Hip replacement surgery, or total hip arthroplasty, is one of the most common joint replacement procedures done in the United States.

WebPT and Limber Health Announce New MSK Measure Set to Equally Compare Clinician Outcomes

Retrieved on: 
Thursday, February 1, 2024
MSK, PROM, Lower, PROMIS, Outcome, PXM, WebPT, MIPS, Intermountain Health, Shoulder, NDI, ATI Physical Therapy, Communication, CMS, Health, Rehabilitation, MDQ, Medicare, Nursing

PHOENIX, Feb. 1, 2024 /PRNewswire/ -- Two-industry leaders WebPT, the rehab therapy platform for Practice Experience Management (PXM), and Limber Health, a digital health solution enabling the delivery of hybrid musculoskeletal (MSK) care, together announce the launch of a single unified outcome measure set.

Key Points: 
  • PHOENIX, Feb. 1, 2024 /PRNewswire/ -- Two-industry leaders WebPT , the rehab therapy platform for Practice Experience Management (PXM), and Limber Health , a digital health solution enabling the delivery of hybrid musculoskeletal (MSK) care, together announce the launch of a single unified outcome measure set.
  • WebPT and Limber Health, accepted the request from CMS and completed this incredible effort to harmonize quality measure sets in collaboration with other industry leaders, including Intermountain Health , Upstream Rehabilitation , and ATI Physical Therapy .
  • The new MSK Measure Set is co-stewarded by WebPT's MSK and Rehabilitative Care Outcomes QCDR and Limber Health's Advancing MSK Care and Rehabilitation QCDR QCDR.
  • Additionally, this new MSK Measure set also includes the PROMIS measures previously supported via Limber Health's former measure set, the LMBR Quality Measures.

Global Memory Chip Market Report, with Profiles of Broadcom, Intel, Micron Technology, Samsung Electronics, SK Hynix and Transcend Information - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 28, 2023
Technology, Hardware, Semiconductor, Other Technology, Samsung, FRAM, 3D XPoint, Personal computer, RRAM, Geography, Micrometre, Research, Acquisition, Patent, NRAM, Intel, Memory, Plant, Broadcom Inc., AI, Internet of things, Micron Technology, COVID-19, Traction, MRAM, SK Hynix, Tablet, Swings, Investment, Samsung Electronics, EPROM, PROM, DRAM, SRAM, Video game

Memory chip sales dropped due to a variety of issues including oversupply, lower demand, higher product prices, and increased competition from alternative storage technologies.

Key Points: 
  • Memory chip sales dropped due to a variety of issues including oversupply, lower demand, higher product prices, and increased competition from alternative storage technologies.
  • Overall, it is projected that the memory chip business will continue to evolve and adapt to changing market conditions and technological advancements.
  • The report provides an overview of the global memory chip market and analyzes market trends.
  • In addition to industry and competitive analysis of the market for memory chips, this report also exhaustively covers patents and company profiles of key players active in the global market.

ChristianaCare Rated as one of the United States’ Best Hospitals by Newsweek for Fifth Consecutive Year

Retrieved on: 
Tuesday, June 20, 2023
College, Newsweek, Human Rights Campaign, Elective surgery, ChristianaCare, Hospital, Quality of life, Healthgrades, College of Healthcare Information Management Executives, MBA, Research, Patient, Gynaecology, U.S. News & World Report, Mother, Patient safety, Diversity, Obstetrics, Knowledge, Statista, Health, Caregiver, MPH, News, PROM, Nursing

“ChristianaCare has gained a global reputation thanks to our unwavering focus to provide expert, high-quality care,” said Kert Anzilotti, M.D., MBA, chief medical officer at ChristianaCare.

Key Points: 
  • “ChristianaCare has gained a global reputation thanks to our unwavering focus to provide expert, high-quality care,” said Kert Anzilotti, M.D., MBA, chief medical officer at ChristianaCare.
  • The recognition by Newsweek echoes other quality recognitions that ChristianaCare has received during the past 12 months:
    For the third consecutive year, Healthgrades named ChristianaCare one of America’s 50 Best Hospitals for 2023.
  • For the seventh consecutive year, the College of Healthcare Information Management Executives named ChristianaCare a Most Wired Health Care Technology Leader.
  • For the second consecutive year, Forbes ranked ChristianaCare as one of the Best Employers for Diversity and Inclusion in the United States.

Orthofix STIM onTrack Recognized for Patient Engagement Innovation in 2023 MedTech Breakthrough Awards Program

Retrieved on: 
Thursday, May 4, 2023
Telehealth, Health care, Medical device, Electronic health record, Spine, Prescription, Global health, STIM, Patient, EHR, Physician, Medical data breach, Health, Research, Medtech, OnTrack, PROM, Nursing

LOS ANGELES, May 4, 2023 /PRNewswire-PRWeb/ -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Orthofix, a global medical device company with a spine and orthopedics focus, has been selected as winner of the "Best Patient Engagement Mobile App" award in the 7th annual MedTech Breakthrough Awards program. The award recognizes the breakthrough innovation of the Orthofix STIM onTrack™ mobile app.

Key Points: 
  • The award recognizes the breakthrough innovation of the Orthofix STIM onTrack ™ mobile app.
  • The STIM onTrack mobile app also provides links to educational patient resources and connects patients with a Patient Care team to help ensure patients understand their treatment regimens.
  • Medical technology advancements can and should be designed to improve patient outcomes," said James Johnson, managing director, MedTech Breakthrough.
  • We extend our sincere congratulations to the entire Orthofix team for taking home a well-deserved 2023 MedTech Breakthrough Award."

Global Memory Chip Global Market 2023: Massive Investments for the Progress of the Semiconductor Sector Present Opportunities

Retrieved on: 
Tuesday, April 18, 2023
Patent, FRAM, Swings, NOR, ROM, DRAM, EPROM, Smartphone, Internet of things, COVID-19, SK Hynix, Samsung, Micrometre, Research, MRAM, 3D XPoint, RRAM, NRAM, Tablet, Plant, Personal computer, Acquisition, Traction, Investment, SRAM, Memory, Intel, City, AI, R, PROM, Video game, Computer data storage, Fine chemical

DUBLIN, April 18, 2023 /PRNewswire/ -- The "Global Memory Chip Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 18, 2023 /PRNewswire/ -- The "Global Memory Chip Market" report has been added to ResearchAndMarkets.com's offering.
  • With the introduction of smart households and smart cities, the demand for memory chips is at an all-time high.
  • Memory is a significant revenue generator for the semiconductor industry, accounting for around 35.3% of overall sales.
  • Overall, it is projected that the memory chip business will continue to evolve and adapt to changing market conditions and technological advancements.

Early Adopter of Remote Therapeutic Monitoring Achieves Significant Clinical and Financial Outcomes

Retrieved on: 
Wednesday, February 22, 2023
MBA, System, BBC, ED, Force, RTM, Patient, Therapy, MSK, CPT, PROM, Communication, Collection, MD, Hospital, Medical device, Nursing

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- Force Therapeutics, a leading full-suite digital care management platform, announced today that Ahmed Siddiqi, MD, MBA, orthopedic surgeon for Orthopedic Institute Brielle Orthopedics in New Jersey, an early adopter of digital and remote musculoskeletal (MSK) care, has identified significant clinical and financial benefits through the Force Therapeutics platform. The Force platform has helped Dr. Siddiqi's practice optimize care at every patient touch point across a whole episode of care, achieving savings through digitally enabled remote care capabilities and supporting successful reimbursement for Remote Therapeutic Monitoring (RTM) from both public and private payers.

Key Points: 
  • The Force platform has helped Dr. Siddiqi's practice optimize care at every patient touch point across a whole episode of care, achieving savings through digitally enabled remote care capabilities and supporting successful reimbursement for Remote Therapeutic Monitoring (RTM) from both public and private payers.
  • The total cost savings through the entire care episode – especially in light of avoidable emergency department visits and readmissions – has a significant financial impact on his practice.
  • "The Force platform is instrumental in how we manage care for each patient from start to finish," said Dr. Siddiqi.
  • Registration for the webinar, "Digital Patient Management – Financial Impact and Opportunities with Dr. Ahmed Siddiqi," at 2pm ET on March 14, is now open .

AACC Releases Updated Guidance to Improve the Use of Point-of-Care Tests for Fertility and Reproductive Health

Retrieved on: 
Thursday, September 1, 2022
Membrane, DRS, Reproductive health, Death, Reproductive medicine, AACC, Ovulation, Temperature, Vital signs, Point-of-care testing, Physician, Diagnosis, Infant, Mass spectrometry, Water, PROM, Fertility, Health, Saliva, FDA, Knowledge, Risk, Woman, Pregnancy, Patient, Medical device, Birth control

WASHINGTON, Sept. 1, 2022 /PRNewswire/ -- AACC has issued a new guidance document with expert recommendations for performing point-of-care tests for fertility and reproductive health.

Key Points: 
  • WASHINGTON, Sept. 1, 2022 /PRNewswire/ -- AACC has issued a new guidance document with expert recommendations for performing point-of-care tests for fertility and reproductive health.
  • Read the guidance document here: https://www.aacc.org/science-and-research/aacc-academy-guidance/use-of-p...
    Point-of-care tests are clinical tests that are performed near the patient instead of in a central lab.
  • Due to their convenience and rapid turnaround times, these tests can help patients to get treatment much faster than traditional tests.
  • This guidance document revises previous recommendations and offers best practices for the use of [point-of-care testing] in fertility and reproductive health."

Hip Innovation Technology Receives FDA Investigational Device Exemption (IDE) Approval to Initiate Landmark Study of its Reverse Hip Replacement System

Retrieved on: 
Tuesday, January 18, 2022
Forward-looking statement, University, Food and Drug Administration, Patient, News, Orthopedic surgery, Intention, Safety, HRS, HIT, Motion, Private Securities Litigation Reform Act, BOCA, Total, Collection, William H. Harris (orthopaedic surgeon), American Academy, Reverse, IDE, AAOS, Roentgen, Dislocation, Arthralgia, Quality of life, PROM, RSA, MD, Technology, Risk, Food, THA, American Academy of Orthopaedic Surgeons, FDA, LLC, Professor, Partnership, Hip, Trial of the century, Medical device, Medical imaging

The clinical study objective is to evaluate the safety and effectiveness of the Reverse HRS in patients undergoing THA.

Key Points: 
  • The clinical study objective is to evaluate the safety and effectiveness of the Reverse HRS in patients undergoing THA.
  • "The Reverse HRS is a unique hip implant design that represents a significant advancement for patients requiring total hip arthroplasty,"said George Diamantoni, Hip Innovation Technology'sCo-Founder and Chief Executive Officer.
  • "In our pivotal study we will further evaluate potential Reverse HRS patient benefits including hip stability at extended ranges of motion, reduced risk of device dislocation, and greater latitude for placement of hip components."
  • Hip Innovation Technology, foundedin 2011, provides market-leading orthopedic device solutions that advances quality of life and quality of care for patients.